diagnostics that combine drugs and devices—this regulatory interaction creates unique compliance challenges.

As an initial action, familiarize yourself with the directives. Key regulatory texts include:

• EU RoHS Directive
• EU REACH Regulation

Understanding these documents will provide a foundational basis for identifying applicable exemptions and navigating complex interdependencies in regulatory compliance.

Step 2: Identify Combination Product Categories

Combination products can fall under multiple categories depending on their intended use and the elements integrated into their design. Understanding the classification of your product is critical for determining whether RoHS requirements and exemptions apply.

The key categories of combination products according to the FDA are:

• Drug-device combinations: Products that integrate a drug with a delivery device, such as pre-filled syringes or inhalers.
• Biologic-device combinations: These include products that combine biologics with a device, for example, drug-coated stents.
• Device-biologic combinations: Devices intended to deliver biologics safely and effectively, like implants.

Identifying where your product fits within these categories allows you to apply relevant compliance measures effectively. Furthermore, consult the FDA’s classifications and your local health authority guidelines to ascertain specific categorization requirements.

Step 3: Assessing RoHS Exemptions Applicable to Combination Products

Once you understand the classification of your combination product, the next step is to evaluate specific RoHS exemptions pertinent to your products. The RoHS directive outlines numerous exemptions where the substance use is limited by specific criteria.

For instance, if your combination product uses lead in its electrical components, you may need to investigate whether an exemption is applicable. Common exemptions include:

• Lead as an alloying element in steel, aluminum, or copper.
• Lead in glass of cathode ray tubes and other glass components.

Documentation Requirements: When seeking RoHS exemptions, it is crucial to maintain the proper documentation. Retain current enterprise resource planning (ERP) data and environmental compliance documentation to substantiate claims of exemption. Document every step of your analysis and retain copies of relevant exemptions from the official directive.

Step 4: Conducting a Hazardous Substance Inventory and Risk Assessment

A comprehensive hazardous substance inventory is essential for compliance with RoHS and REACH. This inventory should list all materials and components used throughout the lifecycle of your combination product. Assess each material against the RoHS restricted substances list.

The following actions are necessary:

• Compile an ongoing material inventory database.
• Utilize the Material Safety Data Sheets (SDS) for components in your product to verify substance classifications and potential risks.
• Assess the SCIP (Substances of Concern In Articles as such or in Complex Objects (Products)) database to identify any SVHC materials categorized under REACH.

Additionally, a risk assessment should evaluate the potential exposure risks both during product usage and post-disposal stages. This holistic approach not only mitigates regulatory risks but also supports sustainable development efforts within your supply chain. Document your assessments diligently, maintaining records that demonstrate compliance and informed decision-making processes.

Step 5: Engaging with Suppliers for Supply Chain Compliance

A critical aspect of RoHS and REACH compliance is effective communication and collaboration with suppliers throughout your supply chain. Engage with suppliers to ensure compliance with RoHS and REACH and verify that all elements of your combination products meet regulatory standards.

Your engagement should include:

• Review of supplier compliance documentation and their processes.
• Requesting Supplier Declarations of Conformity (DoC) to ensure components used are RoHS compliant.
• Regular audits of suppliers to ensure ongoing compliance.

Establish a partnership with your supply chain stakeholders aimed at promoting transparency and mutual compliance goals. Use the above actions to form a collaborative compliance strategy, ensuring all parties are aligned with RoHS and REACH obligations. Maintain records of communications and documentation exchanged throughout this process to support regulatory submissions and audits.

Step 6: Preparing Compliance Documentation and Certification

Once your combination product is assessed for compliance and supplier collaboration is established, the next phase involves compiling and preparing necessary documentation for regulatory certifications and market entry.

Your compliance documentation should include:

• A Declaration of Conformity (DoC) demonstrating compliance with RoHS and REACH requirements.
• Comprehensive Technical Documentation (TD) detailing your product specifications, testing results, and any exemption claims.
• Records of risk assessments, supplier agreements, and up-to-date material inventories.

Documentation Expectations: Ensure rigorous processes for compiling and finalizing documentation, as inaccuracies can lead to significant penalties or delays. Adherence to ICH guidelines facilitates broader acceptance of your documentation across global markets. This structured approach not only supports your compliance but also amplifies your organization’s integrity in product safety standards.

Step 7: Submission to Regulatory Authorities

Upon preparation and compilation of your compliance documentation, the next phase is submission to relevant regulatory authorities. For pharmaceutical combination products, this may involve both health authorities in the US (such as the FDA) and European regulators.

When submitting documentation, ensure:

• Select the correct regulatory pathways based on product classification.
• Accurately complete submission forms and provide comprehensive appendices with supporting documents.
• Register for any required online portals or submission systems, such as the FDA’s [eSubmitter](https://www.fda.gov) or eCTD for EU submissions.

Anticipate queries or requests for further information from regulatory bodies, and establish a dedicated team for post-submission inquiries. Maintain detailed records of submissions and any correspondence with regulatory authorities to ensure effective follow-up.

Step 8: Post-Approval Monitoring and Compliance Management

After obtaining regulatory approval, your compliance responsibilities do not cease. Continuous monitoring and management of compliance with RoHS and REACH are crucial for maintaining market authorization.

Your ongoing compliance program should include:

• Regular audits to ensure supply chain and production practices align with defined environmental standards.
• Continuous review and updates of compliance documentation, especially when changes occur in product components or regulations.
• Active engagement in post-market surveillance to monitor the safety and efficacy of combination products.

Take proactive measures to engage with any updates to RoHS exemptions and REACH regulations to uphold compliance. Establish a system for capturing newly identified hazardous materials and maintain an up-to-date risk assessment matrix. This ongoing vigilance not only ensures compliance but also fosters consumer trust and corporate responsibility.

In conclusion, navigating the complexities of EU REACH compliance consulting and RoHS exemptions in relation to combination products requires a structured and systematic approach. By implementing each of these steps diligently, organizations can ensure compliance with environmental regulations and contribute positively to the sustainability efforts within the pharmaceutical sector.